Acifran (Standard)
Acifran (Standard) (AY 25712 (Standard)) is the analytical standard of Acifran (HY-107579). This product is intended for research and analytical applications. Acifran (AY 25712) is an orally active, full GPR109A and GPR109B agonist and hypolipidemic agent. Acifran reduces Forskolin (HY-15371)-induced cAMP elevation, triggers ERK1/ERK2 phosphorylation, and inhibits lipolysis in adipose tissue through Gi-coupled GPCR activation. Acifran is used for research on atherosclerosis, hyperlipidemia, and type 2 diabetes.
For research use only. We do not sell to patients.
- CAS No.: 72420-38-3
- Formula: C12H10O4
- Molecular Weight:218.21
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 72420-38-3
-
Molecular Weight 218.21
-
Formula C12H10O4
-
SMILES
O=C(C(OC1(C)C2=CC=CC=C2)=CC1=O)O
-
Synonyms
AY 25712 (Standard)
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Acifran (Standard)
- 72420-38-3
- AY 25712 (Standard)
- Reference Standards
- GPR109A
- ERK
- HM74A
- PUMA-G
- HCA2
- HCAR2
- Extracellular signal regulated kinases
- ERK1/ERK2 phosphorylation
- GPR109B
- free fatty acids
- serum triglycerides
- type 2 diabetes
- Gi-coupled GPCR activation
- lipolysis
- fructose-fed rat model of type 2 diabetes
- forskolin-induced cAMP elevation
- Inhibitor
- inhibitor
- inhibit